SenesTech Reports Significant Reductions in Rodent Activity Following Evolve® Deployments in Urban Field Studies
MWN-AI** Summary
SenesTech, Inc. (NASDAQ: SNES), a leader in innovative solutions for rodent population management, has reported striking reductions in rodent activity following the deployment of its Evolve® Rat Birth Control in urban field studies. The company conducted trials in two distinct urban locations, assessing the impact of Evolve over extended periods with standardized tracking plate data.
In the first location, where Evolve was introduced in April 2025, a substantial decrease was observed from August 2025 to January 2026. Rodent presence on tracking plates plummeted from 74% to just 15%, representing a remarkable 79% reduction. Additionally, the density of rodent tracks on active plates decreased by 88%. Although pre-deployment data were unavailable for this area, the results indicate a significant decline in both the prevalence and intensity of rodent activity within five months of the intervention.
In the second location, testing began with a comprehensive baseline survey in August 2025, revealing a worrying 98% presence of rodents prior to Evolve deployment. After five months of baiting, this figure declined to 47%, indicating a 50% reduction in overall presence, complemented by a 71% decrease in track density.
These findings underscore Evolve's efficacy as a non-lethal rodent control strategy that integrates seamlessly into broader pest management programs. Joel Fruendt, President and CEO of SenesTech, emphasized the importance of such objective data for municipalities and pest management professionals considering fertility control measures.
SenesTech remains committed to creating healthier environments through sustainable and effective pest management solutions, reflecting its mission to enhance urban living conditions. For more information, visit SenesTech's official website.
MWN-AI** Analysis
SenesTech, Inc. (NASDAQ: SNES) recently reported promising results from their Evolve® rodent birth control deployments in urban environments, marking significant reductions in rodent activity over monitored periods. With tracking data indicating an extraordinary 79% reduction in rodent presence in the first monitored area and over 50% reduction in a secondary area, these results bolster the potential of Evolve® as a viable solution in integrated pest management strategies.
Investors should consider the implications of such data, especially within urban markets where rodent activity presents public health and infrastructure concerns. The reduction in rodent populations not only enhances community well-being but also creates fertile ground for SenesTech to expand its market presence. Given the increasing global demand for eco-friendly pest control methods and the effective metrics reported, SenesTech is positioned to capitalize on this trend.
Moreover, the objective and measurable field data gathered through tracking plates over a span of five months provides credibility to their claims. This transparency is crucial for municipalities and pest management professionals as they evaluate new pest control methodologies, potentially leading to increased adoption of Evolve® in various cities.
However, investors should remain vigilant about the risks associated with new product adoption, including market acceptance, regulatory hurdles, and site-specific conditions which may affect the efficacy of deployments. It is essential for SenesTech to maintain ongoing communication with stakeholders to alleviate concerns and demonstrate continued efficacy in diverse urban settings.
In summary, SenesTech's promising trial results signal a potential growth opportunity, but investors should weigh these favorable developments against the inherent uncertainties within the pest control sector. As interest in sustainable pest management solutions grows, the company's innovative approach may redefine industry standards, making it a stock to watch in the coming months.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
SURPRISE, Ariz., Feb. 18, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) ("SenesTech" or the "Company"), a leader in birth control solutions for managing rodent populations, today reported significant reductions in rodent activity following multi-month deployments of Evolve® Rat Birth Control in two urban locations. Results were measured using standardized tracking plate data conducted over a five-month period.
Location A – Deployment Initiated April 2025
In the first monitored area, where Evolve placement began in April 2025, tracking plate data collected from August 2025 through January 2026 showed declines in both rodent presence and activity levels.
- The proportion of plates marked with rodent tracks declined from an average of 74% in August 2025 to 15% in January 2026, representing a 79% reduction in overall plate presence.
- Track density on plates with rodent presence decreased by 88% over the same period.
While baseline data prior to the initial April 2025 product placement were not available, these findings indicate that within five months of monitored observation, rodent activity in the surveyed area declined in both prevalence and intensity.
Location B – Trial Initiated August 2025 with Baseline
In the second monitored area, Evolve deployment commenced immediately following completion of an August 2025 baseline survey, allowing for direct pre- and post-treatment comparison.
- Prior to product placement in August 2025, 98% of tracking plates showed rodent presence.
- After five months of baiting, plate presence declined to 47% in January 2026, representing over a 50% reduction in overall presence.
- Track density declined by 71% during the same period.
These results reflect measurable reductions in rodent activity within five months of Evolve deployment at this location, based on both presence and density indicators.
Study Methodology
Rodent activity was assessed using tracking plates placed throughout each monitored area. Plates were evaluated for the presence of rodent tracks and the relative density of markings. Surveys were conducted at consistent intervals to assess changes over time. Results reflect field observations under real-world urban conditions.
"Results and structured studies such as these are critical as municipalities, pest management professionals and other stakeholders evaluate fertility control as part of broader integrated pest management programs. Objective field data can help inform decisions regarding potential additional deployments and consideration of expansion into new locations," said Joel Fruendt, President and CEO of SenesTech.
"It is a really simple concept. We know from the lab and the field that rats eat the product. We know from the lab that if rats eat our bait, they reproduce less. And we know that rat populations decrease when reproduction decreases," continued Fruendt. "Evolve Rodent Birth Control works!"
About SenesTech, Inc.
SenesTech is committed to creating healthier environments by managing animal pest populations through birth control. The company's groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech's mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are effective and sustainable.
For more information, visit https://senestech.com.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of federal securities laws. Forward-looking statements may include statements regarding the effectiveness of Evolve™ in reducing rodent populations, the potential impact of birth control on long-term rodent management, and the potential impact of the reported results, including on the evaluation of additional deployments and expansion into new locations. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Factors that could cause such differences include, among others, variability in field conditions, implementation practices, market acceptance of our products, regulatory considerations, and other risks described in SenesTech's filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them except as required by law.
Investor Contact:
Robert Blum, Lytham Partners, LLC
(602) 889-9700, [email protected]
Company Contact:
Tom Chesterman, SenesTech, Inc.
(928) 233-7533, [email protected]
SOURCE SenesTech, Inc.
FAQ**
How does SenesTech Inc. SNES ensure the long-term effectiveness and sustainability of the Evolve® birth control product in reducing urban rodent populations beyond the initial five-month assessment?
What specific factors led to the significant reduction of rodent activity observed in both urban locations during the Evolve® deployment, according to the results released by SenesTech Inc. SNES?
Can SenesTech Inc. SNES provide insights on potential challenges or risks encountered during the field studies that may affect the scalability of Evolve® in other urban environments?
How does the success of Evolve® in reducing rodent populations impact the overall strategy for pest management programs, as highlighted by SenesTech Inc. SNES's recent findings?
**MWN-AI FAQ is based on asking OpenAI questions about SenesTech Inc. (NASDAQ: SNES).
NASDAQ: SNES
SNES Trading
-1.74% G/L:
$2.26 Last:
204 Volume:
$2.26 Open:
